Background: Impulsivity is a common feature of attention-deficit/hyperactivity disorder (ADHD), and evidence suggests that impulsivity traits may be an indicator of poor prognosis for individuals with bulimia nervosa. To identify whether there is an association between ADHD and bulimia nervosa, the ...
Lisdexamfetamine systemic is used for ADHD, asperger syndrome, binge eating disorder, chronic ... Reviews & ratings 7.5 / 10 1,082 Reviews View more Atomoxetine Atomoxetine is used to treat attention deficit hyperactivity disorder (ADHD). Learn about side ... Reviews & ratings 5.4 / 10 64...
The current findings have implications for treatment response to drugs currently in use (or being developed) for the treatment of overeating and overweight. 展开 关键词: dopamine transporter binge-eating appetite methylphenidate DOI: 10.1038/sj.npp.1301348 被引量: 290 ...
Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Response to psychomotor stimulants is highly variable across individuals. Such inconsistencies are influenced by many factors including drug dose and polym... C Davi...
Nicole wants to test whether eating 9 cupcakes per day increases athletic performance. Both Nicole and her participants know whether they are in the control group or the cupcake group. At a ''rave'' party, Marilyn used ecstasy. ...
Efficacy of methylphenidate as a pyschostimulant in attention-deficit/hyperactive disorder (ADHD); Summary of case study of a 25-year-old Caucasian college student; Comorbidity of ADHD and bulimia; Decline of binge eating with methylphenidate.Schweickert...
Strober, and A. Moskowitz, "Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report," The International Journal of Eating Disorders, vol. 21, no. 3, pp. 299-301, 1997.Schweickert LA, Strober M, Moskowitz A. Efficacy of ...
binge eating disorderobesitypsychotherapytreatment outcomeModafinil is a unique wake-promoting agent. Preclinical studies indicate a mechanism of action which is distinct from that of amphetamine or methylphenidate. To compare the pharmacodynamic profiles of modafinil, methylphenidate, and placebo in humans, ...
METHYLPHENIDATEPHARMACODYNAMICSA correction is presented to the article "Sex differences in subjective and objective responses to a stimulant medication (methylphenidate): Comparisons between overweight/obese adults with and without binge-eating disorder" which appeared in the May 5, 2016 issue....
We report the successful treatment of a case of refractory binge eating disorder (BED) with duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, resulting in complete remission of the patient's bingeing behaviours. This case is discussed in the context of the existing literature on...